Multi-Target Drug Design for Complex Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (10 May 2022) | Viewed by 30534
Special Issue Editors
Interests: systems pharmacology; pharmacoinformatics; coputer-aided drug design
Special Issues, Collections and Topics in MDPI journals
Interests: drug design; medicinal chemistry; neurodegenerative diseases; pharmacology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are organizing a Special Issue of Pharmaceutics, an open access journal focusing on the science and technology of pharmaceutics and biopharmaceutics (IF. 4.421, ranks Q1 in the category of Pharmacology & Pharmacy). The plan is to publish this Special Issue on “Multi-Target Drug Design for Complex Diseases” in July 2021.
For this Special Issue, our main goal is to promote open and multi-disciplinary discussion about the current and promising strategies for multi-target drug design for complex diseases, including, among other topics, experimental and theoretical/computational approaches to identify novel targets, to expand the chemical space of bioactive compounds and to design new models of complex diseases. This Special Issue will accept articles from bioinformatics and molecular pharmacology to medicinal chemistry and clinical pharmacology oriented toward the development of pharmacological therapies for complex diseases. Contributions on these topics are welcome, including original research and reviews.
We look forward to receiving your manuscript submissions for this Special Issue.
Dr. David Ramírez
Prof. Dr. Ana Martínez
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- complex diseases
- multi-target drug design
- pharmacology
- novel therapies
- polypharmacology
- medicinal chemistry
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.